The Enterprise Value as of December 2025 (TTM) for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is 20.60B

According to Genomma Lab Internacional, S.A.B. de C.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.60B. This represents a change of -22.89% compared to the average of 26.71B of the last 4 quarters.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Historical Enterprise Value (quarterly & annually)

How has GNMLF Enterprise Value performed in the past?

The mean historical Enterprise Value of Genomma Lab Internacional, S.A.B. de C.V. over the last ten years is 22.68B. The current 20.60B Enterprise Value has changed 8.98% with respect to the historical average. Over the past ten years (40 quarters), GNMLF's Enterprise Value was at its highest in in the March 2025 quarter at 29.47B. The Enterprise Value was at its lowest in in the September 2023 quarter at 15.05B.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genomma Lab Internacional, S.A.B. de C.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Average Enterprise Value

How has GNMLF Enterprise Value performed in the past?

The current Enterprise Value of Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Enterprise Value vs. Peers

How is GNMLF’s Enterprise Value compared to its peers?

Genomma Lab Internacional, S.A.B. de C.V.’s Enterprise Value is greater than SSY Group Limited (11.84B), greater than Safilo Group S.p.A. (784.56M), less than Netcare Limited (29.50B), less than Towa Pharmaceutical Co., Ltd. (367.30B), greater than BioGaia AB (publ) (9.00B), less than Kissei Pharmaceutical Co., Ltd. (158.58B), greater than Rhoen-Klinikum AG (797.01M), greater than Extendicare Inc. (2.06B), greater than Tong Ren Tang Technologies Co. Ltd. (3.12B), greater than RHON-KLINIKUM AG Unsponsored ADR (797.01M),

Build a custom stock screener for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomma Lab Internacional, S.A.B. de C.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genomma Lab Internacional, S.A.B. de C.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.